VALBIOTIS SA

Valbiotis SA raises €10.2 m to expand natural health products, boost its French sales force, and advance its biotech pipeline, positioning itself for growth on Euronext Growth Paris.

Valbiotis SA: exploring nutrition‑based cardiometabolic solutions amid price volatility—why investors are watching its biotech gamble.